Helmut Schiffl

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi Daily hemodialysis and the outcome of acute renal failure
    Helmut Schiffl
    Department of Nephrology, Medizinische Klinik and Medizinische Poliklinik Innenstadt, Universitat Munchen, Munich, Germany
    N Engl J Med 346:305-10. 2002
  2. ncbi Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients
    Helmut Schiffl
    KfH Dialysezentrum München Laim, Munich, Germany
    Nephrol Dial Transplant 17:1814-8. 2002
  3. ncbi Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient
    Holger Schmid
    KfH Nierenzentrum Muenchen Laim, Department of Internal Medicine, University Hospital Munich, University of Munich, Munich, Germany
    Curr Opin Nephrol Hypertens 20:465-70. 2011
  4. ncbi Effects of dialysis purity on uremic dyslipidemia
    Helmut Schiffl
    KfH Renal Center Munich Laim, Munich, Germany
    Ther Apher Dial 14:5-11. 2010
  5. ncbi Five-year outcomes of severe acute kidney injury requiring renal replacement therapy
    Helmut Schiffl
    Department of Internal Medicine Campus Innenstadt, University of Munich, Munich, Germany
    Nephrol Dial Transplant 23:2235-41. 2008
  6. ncbi Disease severity adversely affects delivery of dialysis in acute renal failure
    Helmut Schiffl
    Department of Internal Medicine, University of Munich, Munich, Germany
    Nephron Clin Pract 107:c163-9. 2007
  7. ncbi Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function
    Johannes Rieger
    Department of Radiology, Medizinische Klinik Innenstadt, Ludwig Maximilians University, Munich, Germany
    Nephrol Dial Transplant 17:824-8. 2002
  8. ncbi Hemodiafiltration and survival of end-stage renal disease patients: the long journey goes on
    Holger Schmid
    Department of Internal Medicine IV Campus Innenstadt, University of Munich, Munich, Germany
    Int Urol Nephrol 44:1435-40. 2012
  9. ncbi New strategies for managing anemia of chronic kidney disease
    Holger Schmid
    KfH Nierenzentrum München Laim, Munich, Germany
    Cardiovasc Hematol Agents Med Chem 10:339-51. 2012
  10. ncbi Update on biomarkers of acute kidney injury: moving closer to clinical impact?
    Helmut Schiffl
    Department of Internal Medicine IV, University of Munich, Munich, Germany
    Mol Diagn Ther 16:199-207. 2012

Collaborators

Detail Information

Publications26

  1. ncbi Daily hemodialysis and the outcome of acute renal failure
    Helmut Schiffl
    Department of Nephrology, Medizinische Klinik and Medizinische Poliklinik Innenstadt, Universitat Munchen, Munich, Germany
    N Engl J Med 346:305-10. 2002
    ..We performed a prospective study to determine the effect of daily intermittent hemodialysis, as compared with conventional (alternate-day) intermittent hemodialysis, on survival among patients with acute renal failure...
  2. ncbi Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients
    Helmut Schiffl
    KfH Dialysezentrum München Laim, Munich, Germany
    Nephrol Dial Transplant 17:1814-8. 2002
    ..Our prospective randomised investigation aimed to analyse the effects of the microbiological quality of dialysis fluid on the course of residual renal function after initiation of haemodialysis...
  3. ncbi Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient
    Holger Schmid
    KfH Nierenzentrum Muenchen Laim, Department of Internal Medicine, University Hospital Munich, University of Munich, Munich, Germany
    Curr Opin Nephrol Hypertens 20:465-70. 2011
    ..Numerous noninterventional studies in patients with chronic kidney disease (CKD) revealed a consistent relationship of LVH with modifiable risk factors attributable to failing renal function, particularly anemia and hypertension...
  4. ncbi Effects of dialysis purity on uremic dyslipidemia
    Helmut Schiffl
    KfH Renal Center Munich Laim, Munich, Germany
    Ther Apher Dial 14:5-11. 2010
    ..Ultrapure dialysis fluid improves potential parameters of cardiovascular risk by decreasing inflammatory reactions, improving uremic dyslipidemia and lowering oxidative stress...
  5. ncbi Five-year outcomes of severe acute kidney injury requiring renal replacement therapy
    Helmut Schiffl
    Department of Internal Medicine Campus Innenstadt, University of Munich, Munich, Germany
    Nephrol Dial Transplant 23:2235-41. 2008
    ..Severe acute kidney injury (AKI) is a common occurrence in intensive care. However, few studies have followed up these patients beyond 12 months after hospital discharge...
  6. ncbi Disease severity adversely affects delivery of dialysis in acute renal failure
    Helmut Schiffl
    Department of Internal Medicine, University of Munich, Munich, Germany
    Nephron Clin Pract 107:c163-9. 2007
    ..This observational study was designed to evaluate the impact of disease activity on delivered single pool Kt/V(urea) in ARF patients...
  7. ncbi Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function
    Johannes Rieger
    Department of Radiology, Medizinische Klinik Innenstadt, Ludwig Maximilians University, Munich, Germany
    Nephrol Dial Transplant 17:824-8. 2002
    ....
  8. ncbi Hemodiafiltration and survival of end-stage renal disease patients: the long journey goes on
    Holger Schmid
    Department of Internal Medicine IV Campus Innenstadt, University of Munich, Munich, Germany
    Int Urol Nephrol 44:1435-40. 2012
    ..There is an urgent need for further randomized controlled trials to confirm previous findings and to identify those ESRD patients that are likely to benefit mostly from HDF...
  9. ncbi New strategies for managing anemia of chronic kidney disease
    Holger Schmid
    KfH Nierenzentrum München Laim, Munich, Germany
    Cardiovasc Hematol Agents Med Chem 10:339-51. 2012
    ....
  10. ncbi Update on biomarkers of acute kidney injury: moving closer to clinical impact?
    Helmut Schiffl
    Department of Internal Medicine IV, University of Munich, Munich, Germany
    Mol Diagn Ther 16:199-207. 2012
    ..It needs to be shown whether assignment to earlier treatment for AKI on the basis of generally accepted biomarker cut-off levels results in a reduction in mortality and an improvement in recovery of renal function...
  11. ncbi Exit-site infections by non-diphtheria corynebacteria in CAPD
    Helmut Schiffl
    KfH Nierenzentrum München Laim, Munich, Germany
    Perit Dial Int 24:454-9. 2004
    ..This study highlights the importance of non-diphtheria corynebacteria as emerging nosocomial pathogens in the population of end-stage renal disease patients on on continuous ambulatory peritoneal dialysis...
  12. ncbi MELAS: a mitochondrial disorder in an adult patient with a renal transplant
    Stephan R Lederer
    KfH Nierenzentrum München West and Nephrologisches Zentrum, Klinikum der Universitat Munchen, Munich, Germany
    Wien Klin Wochenschr 122:363-5. 2010
    ..This case report describes a 58-year-old patient with a 40-year course of a multisystemic illness representing the diagnostic challenges of mitochondrial disease...
  13. ncbi Erythropoiesis stimulating agents and anaemia of end-stage renal disease
    Holger Schmid
    KfH Nierenzentrum Muenchen Laim, Munich, Germany
    Cardiovasc Hematol Agents Med Chem 8:164-72. 2010
    ..The use of ESAs does carry risks such as hypertension, pure red cell aplasia, or cancer, and these agents need to be used judiciously...
  14. ncbi Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin
    Thomas Sitter
    Department of Nephrology, Medizinische Klinik Innenstadt, Ludwig Maximilians University, Munich, Germany
    J Nephrol 15:297-301. 2002
    ....
  15. ncbi Intermittent hemodialysis and/or continuous renal replacement therapy: are they complementary or alternative therapies?
    Helmut Schiffl
    Am J Kidney Dis 40:1097-9. 2002
  16. ncbi Acute effects of hemodialysis on lung function in patients with end-stage renal disease
    Susanne M Lang
    Division of Pneumology, Department of Medicine, Medizinische Klinik Innenstadt, University of Munich, Germany
    Wien Klin Wochenschr 118:108-13. 2006
    ..Regardless of the membrane used, the hemodialysis procedure does not acutely affect lung function in uremic patients on maintenance hemodialysis. Hemodialysis is a safe procedure even in uremic patients with pre-existing lung disease...
  17. ncbi Renal recovery from acute tubular necrosis requiring renal replacement therapy: a prospective study in critically ill patients
    Helmut Schiffl
    Department of Internal Medicine, University of Munich, Germany
    Nephrol Dial Transplant 21:1248-52. 2006
    ..This prospective cohort study was designed to assess the need for short- and long-term dialysis in critically ill patients with severe ATN and to define risk factors for lack of renal recovery...
  18. ncbi Utility of urea kinetic modelling for prescription of adequate intermittent dialysis in critically ill maintenance dialysis patients
    Helmut Schiffl
    Nephrol Dial Transplant 22:2096. 2007
  19. ncbi Daily haemodialysis for acute renal failure
    Helmut Schiffl
    Department of Nephrology Innenstadt, Ludwig Maximilians University of Munich, Germany
    Curr Opin Nephrol Hypertens 11:589-92. 2002
    ..Recent data suggest that alternate day dialysis provides inadequate dialysis dosing in the majority of critically ill patients...
  20. ncbi Rapid decline of residual renal function in patients with late renal transplant failure who are re-treated with CAPD
    Helmut Schiffl
    , Ludwig Maximilians University Munich, Germany
    Perit Dial Int 23:398-400. 2003
  21. ncbi Fluoridation of drinking water and chronic kidney disease: absence of evidence is not evidence of absence
    Helmut Schiffl
    Nephrol Dial Transplant 23:411. 2008
  22. ncbi Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus
    Susanne Dugas-Breit
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilians Universitat, Munchen, Germany
    J Dtsch Dermatol Ges 3:343-7. 2005
    ..The pathogenesis of pruritus in renal disease is not yet understood. Evidence suggests that mast cells play a role; for example, the number of dermal mast cells is increased in patients on hemodialysis...
  23. ncbi Stopping smoking slows accelerated progression of renal failure in primary renal disease
    Helmut Schiffl
    Deaprtment of Internal Medicine, Innenstadt, University of Munich, Germany
    J Nephrol 15:270-4. 2002
    ..Cigarette smoking accelerates the progression of renal failure in primary kidney diseases. It is not known, however, whether stopping smoking slows this accelerated loss of renal function...
  24. ncbi Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients
    Helmut Schiffl
    KfH Nierenzentrum München Laim, Elsenheimerstr 63, D80687 Munich, Germany
    Nephrol Dial Transplant 21:133-7. 2006
    ..While folic acid deficiency causes macrocytic anaemia in non-renal patients, the relevance of altered folate metabolism in anaemia of end-stage renal disease and its response to rHu-EPO is less clear...
  25. ncbi Hemodiafiltration does not increase the risk for mortality in ESRD
    Helmut Schiffl
    Am J Kidney Dis 46:167-8; author reply 168-9. 2005
  26. ncbi Residual renal function should be preserved in haemodialysis patients
    Helmut Schiffl
    Nephrology (Carlton) 12:422; author reply 422-3. 2007